Skip to main content
Back to feed
MarketsSingle-sourceLow
2.0

Lipocine Inc. reports executive or director departure via 8-K/A filing

Lipocine Inc. filed an 8-K/A amendment regarding the departure of directors or officers and associated compensatory arrangements. The filing indicates a change in corporate governance or leadership structure, though specific details on the individuals involved require review of the full document.

SEC EDGAR 8-K Filings3 days agoUSengCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1

Intelligence Tags

#sec#filing#governance#corporate#lipocine

Entities

country
Source

Related signals

8 found